Pediatric observation status: are we overlooking a growing population in children's hospitals?

Michelle L Macy1, Matthew Hall, Samir S Shah

  • 1Department of Emergency Medicine and the Child Health Evaluation and Research (CHEAR) Unit, Division of General Pediatrics, University of Michigan, Ann Arbor, MI, USA. mlmacy@umich.edu

Insights

Observation stays are common for children admitted from the emergency department (ED). Excluding these pediatric observation stays from data may underestimate hospital resource use.

Area of Science:

  • Pediatric hospital medicine
  • Healthcare administration
  • Health services research

Background:

  • Inpatient administrative datasets often exclude observation stays, classifying them as outpatient care.
  • The prevalence of observation status in pediatric hospitalizations is not well-documented.

Purpose of the Study:

  • To analyze trends in observation status and 1-day stays for children admitted from the emergency department (ED).
  • To compare patient characteristics and outcomes between observation and inpatient stays.

Main Methods:

  • Retrospective analysis of the 2004-2009 Pediatric Health Information System (PHIS) database.
  • Involved 16 US children's hospitals providing outpatient and inpatient data.
  • Examined admissions from the ED to observation or inpatient status.

Main Results:

  • Short-stay proportions (observation and 1-day) increased from 37% to 41% (2004-2009).
  • Observation stays exceeded 1-day stays after 2007.
  • Fewer than 25% of observation stays converted to inpatient status; return visits were similar to 1-day stays.

Conclusions:

  • Observation status represents a significant portion of acute pediatric hospitalizations.
  • Excluding observation stays from analyses likely underestimates pediatric hospital resource utilization.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Naturalistic Observations02:30

Naturalistic Observations

If you want to understand how behavior occurs, one of the best ways to gain information is to simply observe the behavior in its natural context. However, people might change their behavior in unexpected ways if they know they are being observed. How do researchers obtain accurate information when people tend to hide their natural behavior? As an example, imagine that your professor asks everyone in your class to raise their hand if they always wash their hands after using the restroom. Chances...